(1R,9S)-(-)-β-Hydrastine - CAS 118-08-1
Catalog number: 118-08-1
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
Molecular Weight:
Hydrastine, a natural alkaloid compound, could be used as a dopamine biosynthesis inhibitor.
Publictions citing BOC Sciences Products
  • >> More
(1R,9S)-(-)-beta-Hydrastine;Hydrastine base
10 mM in H2O (free soluble)
-20ºC Freeze
Hydrastine could be used as a dopamine biosynthesis inhibitor.
Shelf Life:
As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly
Boiling Point:
548.8ºC at 760mmHg
Melting Point:
Canonical SMILES:
1.Enantio-selective inhibition of (1R,9S)- and (1S,9R)-beta-hydrastines on dopamine biosynthesis in PC12 cells.
Yin SY1, Kim YM, Lee JJ, Jin CM, Yang YJ, Ma JJ, Kang MH, Kai M, Lee MK. Neuropharmacology. 2004 Dec;47(7):1045-52.
The inhibitory effects of (1R,9S)- and (1S,9R)-enantiomers of beta-hydrastine (BHS) on dopamine biosynthesis in PC12 cells were investigated. (1R,9S)-BHS decreased the intracellular dopamine content with the IC50 value of 14.3 microM at 24 h, but (1S,9R)-BHS did not. (1R,9S)-BHS was not cytotoxic at concentrations up to 250 microM towards PC12 cells. In these conditions, (1R,9S)-BHS inhibited tyrosine hydroxylase (TH) activity mainly in a concentration-dependent manner (33% inhibition at 20 microM) and decreased TH mRNA level in PC12 cells. The inhibitory patterns of dopamine content and TH activity by (1R,9S)-BHS showed similar behavioral curves. (1R,9S)-BHS at 10-50 microM also reduced the intracellular cyclic AMP level and Ca2+ concentration. In addition, treatment of L-DOPA at 20-50 microM for 24 h increased the intracellular dopamine content to 198-251% compared with the control in PC12 cells. However, the increase in dopamine levels induced by L-DOPA (20-50 microM) was reduced when L-DOPA was combined with (1R,9S)-BHS (10-50 microM).
2.Effects of hydrastine derivatives on dopamine biosynthesis in PC12 cells.
Kim SH1, Shin JS, Lee JJ, Yin SY, Kai M, Lee MK. Planta Med. 2001 Oct;67(7):609-13.
The effects of hydrastine derivatives on dopamine biosynthesis in PC12 cells were investigated. Treatments of PC12 cells with (1R,9S)-beta-hydrastine hydrochloride [(+)-beta-hydrastine HCl] and (1R,9S)-beta-hydrastine [(-)-beta-hydrastine] showed 50.6 % and 33.1 % inhibition of dopamine content at a concentration of 10 microM for 48 h. However, (1S,9R)-beta-hydrastine [(+)-beta-hydrastine] and hydrastinine hydrochloride did not reduce dopamine content. The IC(50) values of (1R,9S)-beta-hydrastine hydrochloride and (1R,9S)-beta-hydrastine were 9.3 microM and 20.7 microM , respectively. Next, the intracellular mechanisms of (1R,9S)-beta-hydrastine hydrochloride in PC12 cells were investigated. Dopamine content decreased at 6 h and reached a minimal level at 24 h after the exposure of PC12 cells to 20 microM (1R,9S)-beta-hydrastine hydrochloride. Tyrosine hydroxylase (TH) activity was inhibited at 6 h following the treatment with (1R,9S)-beta-hydrastine hydrochloride, and was maintained at a reduced level for up to 36 h in PC12 cells (17 - 27 % inhibition at 20 microM), whereas TH mRNA level was not found to alter for 24 h.
3.Effects of (1R,9S)-beta-hydrastine on l-DOPA-induced cytotoxicity in PC12 cells.
Yin SY1, Lee JJ, Kim YM, Jin CM, Yang YJ, Kang MH, Kai M, Lee MK. Eur J Pharmacol. 2004 Mar 19;488(1-3):71-7.
(1R,9S)-beta-Hydrastine in lower concentrations of 10-50 microM inhibits dopamine biosynthesis in PC12 cells. In this study, the effects of (1R,9S)-beta-hydrastine on L-DOPA (L-3,4-dihydroxyphenylalanine)-induced cytotoxicity in PC12 cells were investigated. (1R,9S)-Hydrastine at concentrations up to 250 microM did not reduce cell viability. However, at concentrations higher than 500 microM it caused cytotoxicity in PC12 cells, as determined with the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, TUNEL (terminal deoxynucleotidyltransferase dUTP nick-end labeling) method and flow cytometry. Exposure of PC12 cells to cytotoxic concentrations of (1R,9S)-beta-hydrastine (500 and 750 microM) in combination with L-DOPA (20, 50 and 100 microM) after 24 or 48 h resulted in a significant decrease in cell viability compared with the effects of (1R,9S)-beta-hydrastine or L-DOPA alone, and apoptotic cell death was observed.
4.Effects of (1R,9S)-beta-hydrastine on intracellular calcium concentration in PC12 ce
Yin SY1, Kim YM, Lee JJ, Jin CM, Yang YJ, Park SK, Yoo SK, Lee MK. Biol Pharm Bull. 2007 Aug;30(8):1547-50.
(1R,9S)-beta-hydrastine (BHS) decreases the basal intracellular Ca(2+) concentration ([Ca(2+)](i)) in PC12 cells.(5) This study examined the effects of (1R,9S)-BHS on [Ca(2+)](i) in PC12 cells. (1R,9S)-BHS at 10-100 microM in combination with a high extracellular K+ level (56 mM) inhibited the release of dopamine in a concentration-dependent manner with an IC(50) value of 66.5 microM. BHS at 100 microM inhibited the sustained increase in [Ca(2+)](i) induced by a high K+ level (56 mM), and had an inhibitory effect on the 2 microM nifedipine-induced blockage of the K+ -stimulated sustained increase in [Ca(2+)](i). In addition, (1R,9S)-BHS at 100 microM prevented the rapid and sustained increase in [Ca(2+)](i) elicited by 20 mM caffeine, but did not have an effect on the increase induced by 1 microM thapsigargin, in the presence of external Ca(2+). These results suggest that the active sites of (1R,9S)-BHS are mainly L-type Ca(2+) channels and caffeine-sensitive Ca(2+)-permeable channels in PC12 cells.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products

CAS 14279-91-5 4-Chlorophenylguanidine hydrochloride

4-Chlorophenylguanidine hydrochloride
(CAS: 14279-91-5)

4-Chlorophenylguanidine hydrochloride is the hydrochloride salt of chlorophenylguanidine, which is a specific and potent inhibitor of urokinase. It is a useful ...

CAS 108427-72-1 AS-35

(CAS: 108427-72-1)

AS-35 is used as an antiallergic drug. It controls allergic diseases by inhibiting eosinophil activation.

CAS 2415-24-9 Catalpol

(CAS: 2415-24-9)

Catalpol can be extracted from the herb of Rehmannia glutinosa (Gaert.) Libosch. ex Fisch. et Mey. It primary function is to stimulate the production of adrenal...

Marinopyrrole A
(CAS: 1010732-14-5)

Marinopyrrole A is a small molecule Mcl-1 inhibitor. It could induce Mcl-1 proteasomal degradation without transcriptional downregulation. It has the potential ...

CAS 50-33-9 Phenylbutazone

(CAS: 50-33-9)

Phenylbutazone is used as a non-steroidal anti-inflammatory agent for the treatment of chronic pain, including the symptoms of arthritis. In the United States a...

CGP 43182
(CAS: 150379-37-6)

CGP 43182, a dioxaspiro compound, has been found to a IIA sPLA2 inhibitor that could have potential anti-inflammatory effect and also in influencing the synergi...

CAS 464-49-3 D(+)-Camphor

(CAS: 464-49-3)

(R)-(+)-Camphor is a terpenoid used as a culinary flavouring agent in parts of asia.

CAS 28860-95-9 Carbidopa

(CAS: 28860-95-9)

Carbidopa is an aromatic-L-amino-acid decarboxylase inhibitor with an IC50 of 29 ± 2 μM.

(CAS: 1377239-83-2)

PBTZ169 is a decaprenyl-phosphoribose-epimerase (DprE1) inhibitor. DprE1 is an essential enzyme involved in the cell wall biosynthesis of Corynebacterineae. The...

Canfosfamide Hydrochloride
(CAS: 439943-59-6)

Canfosfamide is a modified glutathione analogue as a small-molecule antineoplastic compound with potential antineoplastic activity. Canfosfamide is selectively ...

CAS 141117-12-6 Celgosivir hydrochloride

Celgosivir hydrochloride
(CAS: 141117-12-6)

Celgosivir hydrochloride is the hydrochloride salt of Celgosivir which is anα-glucosidase inhibitor and inhibits bovine viral diarrhoea virus (BVDV) with an IC5...

CAS 832729-13-2 LF 11

LF 11
(CAS: 832729-13-2)

LF 11 is a peptide based on the lipopolysaccharide-binding region of human lactoferricin. It shows antimicrobial activity against gram-negative and gram-positiv...

CB 966
(CAS: 128312-71-0)

CB 966 is a novel analogues of 1,25-dihydroxyvitamin D3 and it was found to significantly delay the rejection of allogeneic skin grafts in CBA (H-2k) recipient ...

CAS 76150-91-9 TCPOBOP

(CAS: 76150-91-9)

TCPOBOP is an constitutive androstane receptor (mCAR) agonist with EC50 value of 20 nM. But it is effective for the mouse receptor but not for human or rat CAR ...

CAS 5041-82-7 Isorhamnetin-3-O-beta-D-Glucosid

(CAS: 5041-82-7)

Isorhamnetin-3-O-beta-D-Glucoside from S. herbacea is a leading compound for further study as a new drug for the prevention and/or treatment of diabetes and its...

CAS 83657-24-3 Diniconazole

(CAS: 83657-24-3)

Diniconazol is a chemical compound belongs to chlorine group of conazole. It is used as fungicide. It inhibited lanosterol 14 alpha-demethylation catalyzed by a...

(CAS: 83843-49-6)

GYKI-23107 is an antiarrhythmic agent with local anaesthetic activity.

CAS 130465-39-3 A 68930 hydrochloride

A 68930 hydrochloride
(CAS: 130465-39-3)

A 68930 hydrochloride is a potent and selective dopamine D1-like receptor agonist (EC50 = 2.1 and 3910 nM for D1-like and D2-like receptors, respectively).

CAS 248282-01-1 Paquinimod

(CAS: 248282-01-1)

Paquinimod, also known as ABR‑215757, belonging to the class of quinoline-3-carboxamide derivatives, is a S100A9 inhibitor. Paquinimod is an immunomodulatory co...

CAS 603148-36-3 Azeliragon

(CAS: 603148-36-3)

Azeliragon is a potent and orally active RAGE inhibitor as a potential treatment for patients with mild-to-moderate Alzheimer's disease (AD).

Chemical Structure

CAS 118-08-1 (1R,9S)-(-)-β-Hydrastine

Quick Inquiry

Verification code

Featured Items